-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| Academician Hu Shengshou: my country's ability to prevent and treat cardiovascular diseases has improved significantly during the 13th Five-Year Plan |
Science and Technology Daily reporter Ma Aiping
On September 17, at the opening ceremony of the China Heart Conference (CHC) 2021 and the 6th China Vascular Conference (CVC), academician of the Chinese Academy of Engineering , director of the National Center for Cardiovascular Diseases, president of Fuwai Hospital , Chinese Academy of Medical Sciences , and Chinese Heart Conference Chairman Hu Shengshou pointed out that during the "13th Five-Year Plan" period (2016-2020), cardiovascular disease prevention and treatment capabilities and research levels have improved significantly .
During the "Thirteenth Five-Year Plan" period, the central government's investment in health and health increased year by year.
The national fiscal health expenditure increased from 1315.
7.
China’s cardiovascular medical treatment capacity has been significantly improved, and the number of coronary arteries in the country is still growing rapidly, breaking through 1 million cases per year, ranking first in the world
.
China's cardiovascular surgical treatment capability is close to the international advanced level
.
The number of cardiac surgery operations continues to increase, and the surgical mortality rate is steadily decreasing
China's cardiovascular research system is gradually improving.
From 2016 to 2020, nearly 60,000 SCI research papers have been published in China's cardiovascular field.
The total number of papers published, cumulative impact factor and citation frequency rank second in the world
.
However, high-level articles are still lacking, and high-level and original theories, techniques, methods, and product output are insufficient
Hu Shengshou pointed out that in the next 30 years, China's cardiovascular disease will continue to increase, and the burden will continue to increase
.
This is related to the high incidence of cardiovascular disease risk factors caused by the aging of the population, the prevalence of unhealthy lifestyles, and urbanization in China
Hu Shengshou said that the prevention and control of cardiovascular diseases in China should still focus on prevention, with the grassroots as the focus, and strive to realize the main battlefield of cardiovascular disease prevention and treatment from the hospital to the community
